Inogen | INGN - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Accuray USD 127.32M 500.16M 2025-09
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
Chart Industries USD 184.7M 48.7M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Orthofix International USD 130.35M 11.31M 2025-12
Philips EUR 1.31B 127M 2025-12
ResMed USD 279.8M 1.4M 2026-03
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
X T L Biopharmaceuticals USD 706K 50K 2024-12
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03